CCCTG Logo  

Contact | How to Join 

  
       
  HOME
  ABOUT US
  NEWS & EVENTS
  PUBLICATIONS
  » Peer Reviewed
  » Submitted Manuscripts
  » Affiliated Publications
  » Abstracts
   
  GRANTS
  LINKS
  MEMBER LOGIN
 
what's new  
The CCCTG 2010 Spring Meeting will be held on June 14 - 17, 2010 at the Rodd Brudenell River Resort, Charlottetown, PEI More »  
   
 
focus on  

 
   
CCCTG Executive Board
 

 

 

Publications

Abstracts

  1. Czerwonka A, Herridge MS, Marsella A, Matte A, Cameron JI in collaboration with the Canadian Critical Care Trials Group. Needs of Survivors of Mechanical Ventilation and their Family Caregivers Across the Care Continuum: A Pilot Study; Am J Respir Crit Care Med 2010; details requested.
  2. Chu LM, Cameron JI, Kudlow Pak, Penola MM, Matte AL, Tansey CM, Tomlinson G, Herridge MS in collaboration with the Canadian Critical Care Trials Group.  Long term outcomes after prolonged mechanical ventilation: Early results from the Towards Recover Pilot study. Am J Respir Crit Care Med 2010; details requested.
  3. Gaudert C, Watpool I, McArdle T, Roy C, Julien L, Wright D, Grabowski-Comeau A, Brean C, Kraus N, Janz W, McIntyre LA, O'Hara-Banack K and the PRECISE Co-investigators for the CCCTG.  Standardized Documentation to Understand Reasons for Missed Blood Draws for Translational Analyses within a Pilot Randomized Controlled Trial.  Am J Respir Crit Care Med 2010; details requested.
  4. Fox-Robichaud AE, McIntyre LA,  Turgeon A, Green R, Zarychanski R, Bagshaw S, Stiell I, Worster A, Rowe B, Emond M, Dwivedi D, Liaw PC and the PRECISE coinvestigators for the Canadian Critical Care Trials Group and the Canadian Critical Care Translational Biology Group.  The PRECISE Pilot Trial: Temporal Changes in Thrombin Generation, Protein C Levels and Activated Protein C Generation in Early Septic Shock. Am J Respir Crit Care Med 2010; details requested.
  5. McIntyre LA, Turgeon A, Green R, Fox Robichaud A, Fergusson D, Tinmouth A, Cook DJ, Hebert PC, Marshall JC, Finfer S, Bagshaw S, Zarychanski R, Pagliarello G, Stiell I, Worster A, Rowe B, Emond E, Rankin N for the CCCTG.  The PRECISE Fluid Resuscitation Pilot Randomized Controlled Trial: Study Design and Preliminary Feasibility Results.  Am J Respir Crit Care Med 2010; details requested.
  6. Heels-Ansdell D, Walter S, Guyatt G, Warkentin T, Crowther Mark, Geerts W, Berwanger O, Rocha M, Freitag A, Cooper J, Qushmaq I, Zytaruk N, Cook DJ for the PROTECT Investigators, CCCTG and ANZICS-CTG.  Central Statistical Monitoring in an International Thromboprophylaxis Trial.  Am J Respir Crit Care Med 2010; details requested.
  7. Lutz K, Wilton K,  Hall R, Skrobik Y, Vlahakis N, Meade L, Matte A, Meade M, Albert M, Burns K, Barlow Cash B,  Cooper DJ, Klinger JR, Heels-Ansdell D, Cook DJ for the PROTECT Investigators, CCCTG and ANZICS.  Research Ethics Board Approval For An International Thromboprophylaxis Trial. Am J Respir Crit Care Med 2010; details requested.
  8. Vallance S, Potter J, O'Connor A, O'Bree B, Rajbhandari D, McDonald E, Tkaczyk A, Finfer S, Barrett J, Woolfe C, Karachi T, Zytaruk N, Cooper JD, Davies A, Cook DJ for the PROTECT Investigators, CCCTG and ANZICS-CTG. Informed Consent for an International Thromboprophylaxis Trial.  Am J Respir Crit Care Med 2010; details requested.
  9. Lamontagne F, Briel M, Duffett M, Kho M, Burns KEA, Adhikari NK, Turgeon A, Guyatt G, Zhou Q, Cook DJ, Meade MO,for the ACCADEMY and the Canadian Critical Care Trials Group.  Vasopressor Administration Survey: A Survey of Canadian Intensivists.  Am J Respir Crit Care Med 2010; details requested.
  10. Zarychanski R, Turgeon AF, Hebert PC, Cook DJ, Tinmouth A, Kumar A, Mcintyre LL, Fergusson D for the CCCTG.  The use of anticoagulants in severe sepsis and septic shock: A national survey of critical care physicians.  Crit Care Med 2010; details requested.
  11. Duffett M, Burns K, Arnold D, Adhikari N, Kho M, Lamontagne L, Lauzier L, Meade M. Cook DJ for the CCCTG. Consent in critical care trials: a surey of Canadian research ethics boards and critical care researchers. Crit Care Med 2010; details requested.
  12. Crowther C, Zytaruk N, Krolicki K, Duchesne S, Heels-Ansdell D, Sheppard JA, Warkentin TE, Walter SD, Guyatt G, Cook D for the PROTECT INVESTIGATORS, the CCCTG And ANZICSCTG. Inter-rater reliability of the 4ts scoring system for diagnosing heparin induced thrombocytopenia in critically ill patients.   Am Soc Hematol 2009; details requested.
  13. Arnold D, Rabbat C, Lauzier F, Zytaruk N, Heels-Ansdell D, Cook D, for the PROTECT Investigators, CCCTG and ANZICSCTG. Adjudicating Bleeding Outcomes in a Large Thromboprophylaxis Trial in Critical Illness.  Am Soc Hematol 2009; details requested.
  14. Rose L, Burns KEA, Smith O, Marshall J for the CCCTG. Quantifying Threats to the Feasibility of Clinical Trials in Critically Ill Patients. Am J Respir Crit Care Med2009;179:D52:A1580.
  15. Rose L, Burns KEA, Smith OM, Marshall J for the CCCTG. Quantifying Challenges for the Conduct of Pilot Randomized Controlled Trials of Critically Ill Patients. Am J Respir Crit Care Med2009;179:D51:A1577.
  16. Sinuff T, Muscedere J, Cook DJ, Dodek P, Keenan S, Haupt M, Wood G, Tan R, Anderson W, Miletin M, Bouali R, Heyland D for the CCCTG. Measuring appropriate guideline use in the ICU: Guideline adherence or concordance? Am J Respir Crit Care Med2009;179:A3106.
  17. Sinuff T, Muscedere J, Cook DJ, Dodek P, Keenan S, Anderson W, Haupt M, Miletin M, Tan R, Wood G, Bouali R, Heyland D for the CCCTG. Guidelines and Other Patient Safety Initiatives in the ICU: A Multicentre, Time-Series Study. Am J Respir Crit Care Med 2009; 179:A3112.
  18. Sinuff T, Muscedere J, Cook DJ, Dodek P, Keenan S, Anderson W, Haupt M, Miletin M, Tan R, Wood G, Bouali R, Heyland D for the CCCTG. Concordance with Ventilator Associated Pneumonia (VAP) Guidelines. Am J Respir Crit Care Med2009;179:A58359.
  19. Muscedere J, Sinuff T, Cook DJ, Dodek P, Keenan S, Wood G, Tan R, Anderson W, Haupt M, Bouali R, Miletin M, Heyland DK for the Canadian Critical Care Trials Group. Clinical Outcomes of Patients Mechanically Ventilated for Greater than 48 Hours; Preliminary results from the ABATE VAP trial. Am J Respir Crit Care Med2009; 179:A3800.
  20. Muscedere J, Sinuff T, Cook DJ, Dodek P, Keenan S, Wood G, Tan R, Anderson W, Haupt M, Bouali R, Miletin M, Heyland DK for the Canadian Critical Care Trials Group. Variation in Tracheostomy Practice. Am J Resp Crit Care Med 2009; 179:A3075
  21. Adhikari NK, Ferguson ND, Mehta S, Freitag A, Friedrich JO, Granton JT, Zhou Q, Stewart TE, Meade MO for the CCCTG. Current High Frequency Oscillation (HFO) Utilization in Ontario.  Am J Respir Crit Care Med 2009; 179: A3072.
  22. Hand L, Lamontagne F, Ferguson N, Bashir AO, Czarnecka K, Lichty D, Adhikari N, Cook DJ, Meade MO for the CCCTG.. Changes in Respiratory Variables Upon Initiation of High Frequency Oscillation (HFO). Am J Respir Crit Care Med2009; 179:A3821.
  23. Meade MO, Cook DJ, Mehta S, Arabi YM, Keenan S, Ronco JJ, Adhikari NK, Jacka M, Freitag A, Friedrich J, Granton JT, Patel R, Dorscheid D, Ferguson ND for the Canadian Critical Care Trials Group. A Multicentre Pilot Randomized Trial of High Frequency Oscillation in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med2009; 179:A1559.
  24. Ferguson ND, Mehta S, Slutsky A, Stewart TE, Hand L, Zhou Q, Austin P, Cook DJ, Guyatt GH, Meade MO for the CCCTG.  Conversion from Ventilation to High Frequency Oscillation: Physiologic Responses in a Pilot Randomized Trial. Am J Respir Crit Care Med 2009 179:A3651.
  25. Mehta S, Meade M, Cook DJ, Fergusson ND, Hebert P, Antoni K, Steinberg M, Burry L for the Canadian Critical Care Trials Group. SLEAP: A Multicenter Randomized Trial of Daily Awakening in Critically Ill Patients Being Managed with a Sedation Protocol.Am J Respir Crit Care Med2009;179:A1570.
  26. Rocha MG, Cavalcanti M, Teixeira C, Ghiot, Adamy R, Rodrigues A, Pagliosa L, Frosi F, Zeni J, Morandi P, Brandao da Silva N, Oliveira JB, Buelher AM, Berwanger O, Costa Filho R, Silva S, Gutierrez F, Zytaruk N, Cook DJ, et all for the PROTECT Investigators and CCCTG. Consent for an International Thromboprophylaxis Trial: The Brazil Experience. Am J Respir Crit Care Med2009;179:A1583.
  27. Zytaruk N, Meade M, Mehta S, Hall R, Southon J, Heels-Ansdell D, Cook DJ for the PROTECT Investigators and the CCCTG. Adjudication Calibration for Pulmonary Embolism in a Thromboprophylaxis Trial. Am J Respir Crit Care Med 2009; 179:A1582.
  28. Barrett K, Athaide V, Smith OM, McDonald E, Pinto R, Stevenson J, Go S, Elman J, Friedrich JP, Cook DJ, Scales DC, Ferguson ND for the CCCTG.. Proxy Evaluations Rating Methods for Inclusion into Trials (PERMIT 2).  Am J Respir Crit Care Med2009; 179:A1573.
  29. Duffett M, Burns KEA, Kho ME, Lauzier F, Meade MO Cook DJ for the CCCTG. Consent in Critical Care Trials: A Survey of Canadian ICU Clinical Researchers. Am J Respir Crit Care Med2009; 179:A1574.
  30. Keenan SP, Sinuff T for the CCCTG Noninvasive Ventilation Guideline Group. Guidelines for the use of CPAP and Noninvasive ventilation (NIV) in acute respiratory failure. Am J Respir Crit Care Med2009; 179:A3038.
  31. Rose L, Burns K, Smith O, Marshall J for the CCCTG. Quantifying Threats to the Feasibility of Clinical Trials in Critically-ill Patients. Am J Respir Crit Care Med 2009;179:A1580.
  32. Rose L, Burns K, Smith O, Marshall J for the CCCTG. Quantifying Challenges to the Conduct of Pilot Randomized Controlled Trials of Critically Ill Patients. Am J Respir Crit Care Med 2009;179:A1580.
  33. Turgeon A, Lauzier F, Burns KE, Fergusson D, Meade MO, Zygun D, Scales D, Zarychanski R, Moore L, Kanji S, McIntyre LL, Pagliarello G, Hebert PC, for the Canadian Critical Care Trials Group.  Determining neurological prognosis in patients with severe traumatic brain in jury: A survey of Canadian intensivists. Critical Care 2009;13 (suppl 1):P88, S37
  34. Turgeon A, Lauzier F, Scales D, Burns K, Bernard F, Zygun d, Congdung T, Moore L, Meade M, Fergusson DA for the Canadian Critical Care Trials Group. Practice variation in the management and treatment of increased intracranial pressure in severe tramatic brain injury in Canada: a Canadian multicentre retrospective cohort study. Crit Care Med 2009 Vol. 37, No.12 (suppl) A435.
  35. Turgeon A, Lauzier F, Burns K, Simard JF, Scales D, Bernard F, Moore L, Zygun D, Meade M, Fergusson DA for the Canadian Critical Care Trials Group. Mortality and incidence of withdrawal of life support measures in ICU patients with severe TBI: a Canadian multicenter retrospective study. Crit Care Med 2009 Vol. 37, No.12 (suppl) A389.
  36. Zarychanski R, Turgeon A, Hébert PC, Cook D, Tinmouth A, Kumar A, McIntyre LL, Fergusson D for the Canadian Critical Care Trials Group. The use of anticoagulants in severe sepsis and septic shock: a national survey of critical care physicians. Crit Care Med 2009 Vol. 37, No.12 (suppl) A427.
  37. Tinmouth A, Pretorius R, Hebert P, Blajchman M, Fergusson D, Lacroix J, for the ABLE investigators and for the Canadian Critical Care Trials Group. Assessing the beliefs and practices of transfusing RBCs with prolonged storage: A survey of Canadian critical care physicians. American Association of Blood Bankers (AABB) Annual Meeting, Montreal, October 4-7, 2008.
  38. Tucci M, Willems A, Toledano BJ, Hume H, Lacroix J Hébert PC, Ducruet T for the Canadian Critical Care Trials Group. Association between length of red blood cell storage and multiple organ dysfunction syndrome in pediatric intensive care. American Association of Blood Bankers (AABB) Annual Meeting, Montreal, October 4-7, 2008.
  39. Ferguson ND, Scales DC, Pinto R, Cook DJ, Guyatt GH, Schunemann HJ, Marshall JC, Stewart TE, Herridge MS, Meade MO, for the Canadian Critical Care Trials Group.  Integrating mortality and morbidity outcomes: quality-adjusted life years in critical care trials. Intensive Care Medicine 2008; S191.
  40. Badia JR, Meade MO, Hand L, Mehta S, Clarke F, Cook DJ, Matte A, Granton JT, Friedrich JO, Adhikari NK, Code K, Smith OM, Arabi Y, Patel R, Dupuis K, Langis N, Lessard M, Murray L, Cooper DJ, Ronco J, Autio R, Stewart TE, Ferguson ND for the OSCILLATE Investigators and the Canadian Critical Care Trials Group.  Identifying and Excluding Patients for Enrolment in ARDS Trials.  Proc Am Thor Soc 2008;177:A816b.
  41. del Sorbo L, Badia JR, Vasquez D, Meade MO, Cook DJ, Granton JT, Friedrich JO, Arabi Y, Patel R, Lessard M, Cooper DJ, Adhikari NK, Ronco J, Stewart TE, Ferguson ND for the OSCILLATE Investigators and the Canadian Critical Care Trials Group. Effect of Disease Severity on Ventilatory Strategies in Patients with ARDS.  Proc Am Thor Soc 2008;177:A629b.
  42. Vasquez D, Badia JR, del Sorbo L, Meade MO, Mehta S, Cook DJ, Granton JT, Friedrich JO, Adhikari NK, Arabi Y, Patel R, Lessard M, Cooper DJ, Ronco J, Stewart TE Ferguson ND for the OSCILLATE Investigators and the Canadian Critical Care Trials Group. Modifying the AECC Definition of ARDS: Impact on Patient Identification and Outcomes. Proc Am Thor Soc 2008;177:A818c.
  43. Herridge MS, Matte AL, Tansey CM, Lee C, Adhikari N, Batt J, Dos Santos C, Fergusson N, Fowler R, Freidrich J, Mehta G, Scales D, Sinuff T, Rocker G, Marshall JC, Cook DJ for the CCCTG.  Outcomes after chronic critical illness: The Towards RECOVER Cohort Study. Proc Am Thor Soc 2008; 177:A638a
  44. Zytaruk N, Yeo C, McDonald E, Hand L, Sonnema L, Harvey J, Smith O, Hammond L, Julien L, Sirois P, Ganz A, Matte F, Auld A, Tkaczyk S, Vallance C, Wynne B, Bojilov I, Neas J, Foxall M, Lewis I, Watpool T, McArdle D, Heels-Ansdell D, Heyland D, Cook DJ for the CCCTG. Informed consent to randomize patients in a thromboprophylaxis trial. Proc Am Thor Soc 2008;177:A40c.
  45. Yeo C, Zytaruk N, Burns K, Wen V, McDonald E, Harvey J, Hammond S, Julien L, Sirois C, Matte A, McGrath-Chong M, Weatherburn C, Autio R, Auld F, Tkaczyk A, Duffett M, Bojilov B, Hand L, Blais M, Laberge N, Mehta S, Muscedere J, Meade M, Skrobik Y, Cooper J, Cook DJ for the CCCTG. Enrolment of medical-surgical icu patients in a thromboprophylaxis trial. Proc Am Thor Soc 2008;177:A41a.
  46. McIntyre LL, Fergusson D, Cook DJ, McArdle T, Watpool I, Rankin N, Dhingra V, Granton J, Taljjard M, Magder S, Stiell I, Hebert PC for the Canadian Critical Care Trials Group. Deferred consent in an early septic shock resuscitation trial. Proc Am Thor Soc 2008;177:A42b.
  47. Fowler R, Pinto R, Sud S, Chan B, Mittmann N, Geerts W, Murray L, Cooper J, Wagner T, Gould M, Hennessy D, Dean S, Doig C, Anis A, Dodek P, Guyatt G, Zytaruk N, Cook DJ for the CCCTG. Variability of direct medical costs among centers and countries in the prospective economic evaluation of the prophylaxis for thromboembolism in critical care trial. Crit Care Med 2008;35; 12:A573.
  48. McIntyre LA, Fergusson D, Cook DJ, Rankin N, Dhingra V, Granton J, Magder S,  Taaljard M, Hebert PC for the CCCTG.  Fluid Resuscitation for the Management of Early Septic Shock (FINESS):A Pilot Randomized Controlled Trial.  Crit Care Med 2008;35:12: A395098.
  49. Ferguson ND, Smith OM, Barrett K, Li A, Pinto R,M. Ratnapalan M, Friedrich JO, Lazar NM, Cook DJ, Scales DC for the Canadian Critical Care Trials Group. Screening for Capacity Amongst ICU Survivors in the Patient Evaluations Rating Methods for Inclusion in Trials (PERMIT) Pilot Study. Intensive Care Med 2007; 33:S112.
  50. Douketis J, Cook DJ, Zytaruk N, Heels-Ansdell D, Anderson D, Geerts W, Rabbat C, Meade M, Guyatt G, Crowther M for the PROTECT Investigators and the Canadian Critical Care Trials Group. Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The DIRECT (Dalteparin's Influence on REnally Compromised anti-Ten-A) Study.  J Thromb Haemostasis 2007;5 (suppl 1):PS-680.
  51. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, Gauvin F, Collet JP, Toledano BJ, Robillard P, for the Canadian Critical Care Trials Group and PALISI Network. Transfusion Requirements In Pediatric Intensive Care Units Study - A Multicenter Randomized Controlled Noninferiority Clinical Trial (ISRCTN37246456). Proc Am Thor Soc 2008;A508e
  52. Dodek PM, Muscedere J, Heyland DK, Cook DJ, Keenan SP and the Canadian Critical Care Trials Group.  Prevention of Ventilator-Associated Pneumonia (VAP): Updated Evidence-Based Clinical Practice GuidelinesProc Am Thor Soc2007; A217c
  53. Muscedere J, Heyland D, Dodek P, Keenan S, Cook D and The Canadian Critical Care Trials Group. Evidence-Based Clinical Practice Guidelines for Ventilator-Associated Pneumonia (VAP): Diagnosis and Treatment.  Proc Am Thor Soc 2007; A105e
  54. Scales DC, Smith OM, Barrett K, Baum M, Li A, Kraus S, Lutz K, McDonald E, Rosenberg J, Chapman K, Pinto R, Ratnapalan M, Soliven J, Friedrich JO, Lazar NM, Cook DJ, ND Ferguson ND for the Canadian Critical Care Trials Group. Patient Evaluations Rating Methods for Inclusion in Trials (PERMIT) Pilot Study.  Proc Am Thor Soc 2007; 175:508b.
  55. Scales DC, Riva-Cambrin J, Le K, Cook DJ, Granton JT for the Canadian Critical Care Trials Group.  Prophylaxis against venous thromboembolism (VTE) in neuro-intensive care patients:  Survey of Canadian practice.  Proc Am Thor Soc2007; 175:A597d
  56. Heels-Ansdell D, Zytaruk N, Blythe D, Rischbieth A, Hebert P, Menon K, Erikson S, Fowler R, Lutz K, Marshall J, Cook D for the Canadian Critical Care Trials Group.  Enrolment of ICU Patients into Clinical Studies: Interim Survey Report of CCCTG. Proc Am Thor Soc2007; 175:A508d
  57. Zytaruk N, Hebert P, Blythe D, Rischbieth A, Menon K, Erikson S, Fowler R, Lutz K, Doig C, Heels-Ansdell D, Meade M, Cook D for the CCCTG and ANZICS-CTG.  Co-enrolment in the ICU: An Interim Survey Report of CCCTG & ANZICS-CTG.Proc Am Thor Soc 2007;175:A593d.
  58. Sinuff T, Thabane L, Linkins L, Treleaven D, Patel R, Rabbat C, Lee A, O'Donnell M, Meade M, Guyatt G, Geerts W, Crowther M, Anderson D, Zytaruk N, Marshall J, Douketis J, Cook D for the DIRECT Investigators and the Canadian Critical Care Trials Group.  Data Monitoring and Event Adjudication in an ICU Observational Study of Thromboprophylaxis.  Proc Am Thor Soc2007; 175:A780c
  59. Zytaruk N, Harvey J, Matte A, Steinberg M, Watpool I, McArdle T, Lewis MJ, Foxall J, Smith O, Sirois C, Code K, Bojilov B, Dale C, Wynne C, Duffett M, McDonald E, Tkaczyk A, Duchesne S, Woods K,  DeCampos I, Richards A, Skrobik Y, Albert M, Pagliarello G, Granton J, Fowler R, Freitag A, Karachi T, Freidrich J, Marshall J, Hebert PC, Mehta G, Clarke F, Heels-Ansdell D, Douketis J, Cook DJ for the DIRECT Investigators and the Canadian Critical Care Trials Group.The DIRECT Influence of Low Molecular Weight Heparin in Renal Insufficiency in ICU. Proc Am Thor Soc2007; 175:A593f
  60. McDonald E, Tkaczyk A, Zytaruk N, Julien L, Steinberg L, Sivanantham V, Hammond S, Myers M, Sirois C, Smith O, Wen V, Smith L, Logie S, Morrissey J, Knox L, Masur J,  Weatherburn C, Vallance S, Clarke FC, Wei X, Cooper DJ, Cook DJ for the Canadian Critical Care Trials Group and ANZICS-CTG. PROTECT- TIMES (Time-In-Motion Evaluation Study).Proc Am Thor Soc2007;175:A594a.
  61. Zytaruk N, D Cook D, Albert M, Sirois C, Williamson D, Hebert P, Granton J, Mehta G, Skrobik Y,  Langevin S, Poirier S, Crowther M, Geerts W, Rabbat C, Guyatt G, Heels-Ansdell H, Sheppard J, Greinacher A, Warkentin TE, for the Canadian Critical Care Trials Group.  Heparin-induced Thrombocytopenia (HIT) in the Medical-Surgical ICU.Proc Am Thor Soc2007; 175:A598a
  62. Parker CM,  Kutsiogiannis J, Muscedere J, Cook D, Dodek P, Day A, Heyland DK for the Canadian Critical Care Trials Group. Outcomes from with ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas: Results from Canadian ICUs.  Crit Care 2007;11(Suppl 2): P89. 
  63. Heyland DK, Dodek P, Muscedere J, Day A, Cook D for the Canadian Critical Care Trials Group. A randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.  Crit Care 2007;11(Suppl 2): P95
  64. Delisle M, Williamson D, Perreault M, Albert M, Jiang X, Heyland DK for the Canadian Critical Care Trials Group. Candida airway colonization is associated with worse outcomes. Critical Care 2007;11(Suppl 2): P110.
  65. Heyland K, Dhaliwal R, Drover J, Muscedere J, Day A, Cook DJ, Jones G, Pagliarello G, Albert M, Chittock D for the REDOXS© Steering Committee and the Canadian Critical Care Trials Group.  Feasibility of the REDOXS© Study: REducing Deaths due to OXidative Stress.  A Randomized Pilot Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients.  Crit Care 2007;11(Suppl 2): P154.
  66. Turgeon A, Cardinal M, Fergusson DA, Pagliarello J, Meade M, Zygun D, Lauzier F, Burns KE, Hébert PC for the Canadian Critical Care Trials Group. Early prediction of neurological prognosis post traumatic brain injury: a systematic review of prognostic models.  Am J Resp Crit Care Med 2007 (suppl) A218.
  67. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, Gauvin F, Collet JP, Toledano BJ, Robillard P, au nom des chercheurs de l'étude TRIPICU, du Canadian Critical Care Trials Group et du Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Une politique restrictive de transfusion d'érythrocytes est sécuritaire chez des enfants stables traités en réanimation pédiatrique : un essai clinique randomisé multicentrique de non-infériorité (ISRCTN37246456). 35e Congrès annuel de la Société de Réanimation de Langue Française, Paris, janvier 2007. Réanimation 2007;16:S37-8.
  68. Tucci M, Lacroix J, Toledano BJ, Hutchison JS, Joffe A, Wensley D, on behalf of the Canadian Critical Care Trials Group. Inflammatory cytokines and red blood cell (RBC) transfusion in critically ill children. Crit Care Med 2006;334:A72.
  69. Tucci M, Willems A, Toledano BJ; Hume H, Lacroix J, Hébert PC, On behalf of the Canadian Critical Care Trials Group and the, PALISI Network. Association between length of red blood cell (RBC) storage and multiple organ dysfunction syndrome (MODS) in pediatric intensive care. Crit Care Med 2006;334:A72.
  70. Willems A, Harrington K, Biarent D, Joffe A, Tucci M, Lacroix J, on behalf of the Canadian Critical Care Trials Group. Transfusion threshold and outcome following pediatric cardiac surgery. Society of Critical Care Medicine, 36th Critical Care Congress, Orlando, February 7-11, 2007. Crit Care Med 2006;334:A11.  
  71. Lacroix J, Hébert PC, Collet JP, Ducruet T, Gauvin F, Hume HA, Hutchison JS, Toledano B, Tucci M, for the Canadian Critical Care Trials Group and the Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion requirements in pediatric intensive care units: A multicenter randomized controlled clinical trial. Transfusion 2006;46:2A (P4-030A).
  72. Ferguson ND, Adhikari NKJ, Scales DC, Fowler RA, Chapman M, Baker AJ, Cook DJ, Meade MO, and the Canadian Critical Care Trials Group.  Neurological ICU Extubation Strategy Utilisation and Reintubation Outcomes (NEURO) Pilot Study.  Intensive Care Medicine 2006; 32:S115.
  73. Steinberg M, Aarts MW, Parkes R, Ferguson ND, Rizoli SB, McLeod RS, Marshall JC, and the Canadian Critical Care Trials Group.  Empiric Antimicrobial Therapy for Suspected ICU-acquired Infection:  The AATICC Pilot Study.  Intensive Care Medicine 2006; 32:S113.
  74. Herridge MS, Tansey CM, Matte AL, Diaz-Granados N, Mehta S, Guest C, Mazer CD, Al-Saidi F, Cooper AB, Stewart T, Barr A, Cook DJ, Slutsky AS, Cheung AM, for the Canadian Critical Care Trials Group.  Five year pulmonary, functional and quality of life outcomes in ARDS survivors. Proc Am Thor Soc2006; 3:A831d.  
  75. Smith O, Steinberg M, Campbell D, Hornby K, McDonald E, Watpool I, Matte A for the Canadian Critical Care Research Coordinators Group.  Standard Operating Procedures for Critical Care Research in Canada.  Proc Am Thor Soc 2006;A379f.
  76. Muscedere JG, Heyland DK, Dodek P, Cook DJ for the Canadian Critical Care Trials Group. A randomized trial of invasive diagnostic techniques and empiric broad-spectrum antibiotics for suspected ventilator-associated pneumonia. Proc Am Thor Soc2006; 3:A525a.
  77. Smith OM, Ferguson ND, Friedrich JO, Barrett K, Kirshenbaum GS, Li A, Lazar NM, Cook DJ, Scales DC and the Canadian Critical Care Trials Group.  Importance of pre-testing for the patient evaluations rating methods for inclusion in trials (PERMIT) pilot study.  Proc Am Thor Soc2006; 3:A384c.
  78. Zytaruk N, Douketis J, Meade M, Crowther MA, Guyatt G, Geerts W, Anderson D, Skrobik Y, Albert M, Hebert P, Pagliarello G, Granton J, Fowler R, Freitag A, Karachi T, Rabbat C, Mehta G, Rocker G, Poirier G, Marshall J, Cook DJ and the Canadian Critical Care Trials Group.  Dalteparin's influence on the renally compromised: anti-ten-a: the DIRECT study.  Proc Am Thor Soc2006; 3:A738c.
  79. Parker C, Kutsiogiannis J, Muscedere J, Cook DJ, Dodek PE, Day A, Heyland DK for the Canadian Critical Care Trials Group.  Prevalence and Risk Factors for Ventilator-associated Pneumonia caused by multidrug-resistant organisms or pseudononas aeruginosa in Canadian ICUs. Proc Am Thor Soc 2006; 3:741c.
  80. Doherty DR, Parshuram CS, Hoskote A, Goia C, Joffe A, Choong K, Joffe A, Tucci M, Bohn D, Hutchison J for the Canadian Critical Care Trials Group.  Hypothermia therapy after pediatric cardio-respiratory arrest. American Heart Association Scientific 2005, Resuscitation Science Symposium Abstract 86, page 24-45.
  81. Marshall JC, Cook DJ, for the Canadian Critical Care Trials Group. Barriers to investigator-initiated ICU research: A survey of the Canadian Critical Care Trials Group. Crit Care Med 2006;33(12):suppl.M113A 
  82. Joffe A, Muscedere J, Marshall J, Su Y, Heyland DK  for the Canadian Critical Care Trials Group. Safety of targeted antibiotic therapy for ventilator associated pneumonia (VAP). Crit Care Med 2006;Dec;34(12):A102
  83. Albert M, Friedrich JO, Adhikari NKJ, Day A, Heyland DK for the Canadian Critical Care Trials Group. Gram stain is a poor predictor of final culture result in ICU patients with suspicion of ventilator-associated pneumonia. Crit Care Med 2006;Dec;34(12):A3.
  84. Liet JM, Millotte B, Tucci M, Laflamme S, Creery D, Ducruet T, Lacroix J, Canadian Critical Care Trials Group. Traitement des bronchiolites graves à VRS par hélium. Étude multicentrique contre placebo. 33e Congrès annuel de la Société de Réanimation de Langue Française, Paris, janvier 2005. Réanimation 2005;14:S50.
  85. Bourdages M, Bigras JL, Farrell CA, Hutchison JS, Lacroix J, avec le soutien du Canadian Critical Care Trials Group. Effet de l'hypothermie modérée sur l'incidence des troubles du rythme cardiaque chez les enfants victimes d'un traumatisme crânien sévère. 33e Congrès annuel de la Société de Réanimation de Langue Française, Paris, janvier 2005. Réanimation 2005;14:S99.
  86. McIntyre LA, Fergusson DA, Hutton B, Cook DJ, Bell D, Dhingra V, Magder S, Hébert PC for The Canadian Critical Care Trials Group.  Is quantity of fluid administered in early severe sepsis associated with hospital mortality?  Am J Resp Crit Care Med 2005;2:A43.
  87. McIntyre LA, Fergusson DA, Hutton B, Cook DJ, Bell D, Dhingra V, Magder S, Rose N, Hébert PC for The Canadian Critical Care Trials Group.  Practice variation in resuscitation of patients with severe sepsis.  Am J Resp Crit Care Med 2005;2:A43.
  88. Henderson WR, Dhingra VK, Chittock DR, Ronco JJ, in association with The Canadian Critical Care Trials Group.  Survival using glucose algorithm regulation (SUGAR) trial - Pilot data.  Am Rev Resp Crit Care Med 2005;2:A37.
  89. Herridge MS, Tansey CM, Matte-Martyn A, Diaz-Granados N, Mehta S, Guest C, Mazer CD, Al-Saidi F, Cooper AB, Stewart T, Barr A, Cook D, Slutsky AS, Cheung AM for The Canadian Critical Care Trials Group.  Four-year pulmonary, functional and QOL outcomes in ARDS survivors.  Am J Resp Care Med  2005;2:A245.
  90. McDonald E, Clarke F, Dale C, Davidson, Farrell R, Handl L, McArdle T, Smith O, Steinberg M, Watpool I, Ward R, Heels-Andsell D, Cook DJ for The Canadian Critical Care Trials Group.  ICU research coordinator activities:  A multicenter time in-motion study.  J Crit Care 2005;9:P267
  91. McIntyre L, Fergusson D, Cook D, Hébert PC for The Canadian Critical Care Trials  Group.  Physician resuscitation practices in early septic shock:  A Canadian survey.  Toronto Critical Care Medical Symposium. Can J Anesthesia 2004. 
  92. Cheung C, Alibhai SMH, Robinson M, Chittock D, Drover J, Skrobik Y, for the Canadian Critical Care Trials Group. Canadian Physicians' Approach to ICU Delirium Diagnosis and Management: A Survey. Toronto Critical Care Medicine Symposium. Can J Anesthesia 2004. 
  93. Liet JM, Millotte B, Tucci M, Laflamme S, Creery D, Ducruet T, Lacroix J for The Canadian Critical Care Trials Group.  Traitement des bronchiolites graves à VRS par hélium.  Étude multicentrique contre placebo.  33e Congrès annuel de la Société de Réanimation de Langue Française, Paris, janvier 2005.  Réanimation 2005;14:S50.
  94. Bourdages M, Bigras JL, Farrell CA, Hutchison JS, Lacroix J, avec le soutien du Canadian Critical Care Trials Group.  Effet de l'hypothermie modérée sur l'incidence des troubles du rythme cardiaque chez les enfants victimes d'un traumatisme crânien sévère.  33e Congrès annuel de la Société de Réanimation de Langue Française, Paris janvier 2005. Réanimation 2005;14:S99.
  95. McIntyre LA, Fergusson DA, Cook DJ, Magder S, Bell D, Dhingra V, Hébert PC for The Canadian Critical Care Trials Group.  Are delays in the recognition and initial management of patients with severe sepsis associated with hospital mortality?  Crit Care Med 2004;31(12) (Suppl) A75.
  96. McDonald E, Poirier G, Hébert P, Pagliarello J, Rocker G, Langevin S, LeBlanc FF, Mehta S, Skrobik Y, Fowler R, Granton J, Freitag A, Jones G, Cooperm DJ, Meade M, Guyatt GH, Anderson D, Geerts W, Crowther M, Zytaruk N, Griffith LE, Cook DJ for the PROTECT Investigators and The Canadian Critical Care Trials Group.  Prophylaxis for thromboembolism in critical care trial.  American Society of Hematology  2004; 104(ii):1784.
  97. McDonald E, Dale C, Pleasance S, McNeil A, Harvey J, Wynne C, Duffett M, Provost L, Rioux A, Larouch G, Davidson C, Watpool I, McArdle T, Foxall J, Bouwers K, Lewis MJ, Zytaruk N, Griffith LE, Crowther M, Cook DJ, for the PROTECT Investigators and The Canadian Critical Care Trials Group.  Anti-Xa levels in critically ill patients receiving Dalteparin for thromboprophylaxis.  American Society of Hematology  2004;104(ii):4075.
  98. McDonald E, Kho M, Wynne C, Duffet M, McNeil A, Provost L, Rioux A, LaRouche G, Davidson C, McArdle T, Watpool T, Foxall J, Lewis M, Pagliarello J, Jones G, Meade M, Crowther M, Rocker G, Cook DJ for The Canadian Critical Care Trials Group.  Multicenter RCT pilot studies:  Exclusion criteria revisited.  Am J Resp Crit Care Med 2004;169(7):A257.
  99. Clarke FJ, Griffith L, McDonald E, Hoad N, Rabbat C, Meade M, Guyatt GH, Devereaux PJ, Geerts W, Wells P, Crowther M, Crook DJ, for The Canadian Critical Care Trials Group. Deep vein thrombosis: Clinically silent in the ICU. Am J Resp Crit Care Med 2004;169(7):A784.
  100. Cheung AM, Tansey CM, Tomlinson G, Diaz-Granados N, Matte-Martyn A, Al-Saidi F, Cooper AB, Guest C, Mazer D, Mehta S, Stewart TE, Cook DJ, Slutsky AS, Herridge MS, for The Canadian Critical Care Trials Group. Two-year health care utilization and costs in survivors of the Acute Respiratory Distress Syndrome (ARDS). Am J Resp Crit Care Med 2004;169(7):A780.
  101. Herridge MS, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest C, Mazer D, Mehta S, Stewart TE, Cook DJ, Slutsky AS, Cheung AM, for The Canadian Critical Care Trials Group. Three year pulmonary, functional and QOL outcomes in ARDS survivors. Am J Resp Crit Care Med 2004;169(7):A18.
  102. Clarke FJ, Matte-Martyn A, Martinez C, Dale C, Sirois C, Harvey J, Harry C, Potter J, Skrobik Y, Mehta S, Albert M, Fowler R, Rabbat C, Cooper J, Finfer S, Cook DJ, Granton J, for The Canadian Critical Care Trials Group. Pre-randomization multicenter research activity: A pilot trial. Am J Resp Crit Care Med 2004;169(7):A625.
  103. Zytaruk N, Cook DJ, Meade M, Rocker G, Poirier G, Langevin S, LeBlanc F, Hebert P, Mehta S, Granton J, Freitag A, Guyatt G, Anderson D, Geerts W, Crowther M, for The Canadian Critical Care Trials Group. Prophylaxis for thromboembolism in critical care trial: A pilot study. Am J Resp Crit Care Med 2004;169(7):A666.
  104. Zytaruk N, Cook DJ, Meade M, Crowther M, Guyatt G, Griffith L, Granton J, Marshall J, and Geerts W, for The Canadian Critical Care Trials Group. Clinically important DVT in the ICU: A survey of intensivists. Am J Resp Crit Care Med 2004;169(7):A866.
  105. Sinuff T, Cook DJ, Rocker G, Griffith L, Walter SD, Fisher M, Dodek P, Sjokvist P, McDonald E, Marshall J, Levy M, Guyatt G, for The Canadian Critical Care Trials Group. Resuscitation directives in the intensive care unit. Am J Resp Crit Care Med 2004;169(7):A623.
  106. Rocker G, Cook DJ, Griffith L, Dodek P, Sjokvist P, Finfer S, McDonald E, Lazar N, Leasa D, Levy M, Varon J, Sinuff T, Guyatt G, for The Canadian Critical Care Trials Group. Physician predictions of ICU survival: A multicenter study  Am J Resp Crit Care Med 2004;169(7):A624.
  107. Patel R, Griffith L, Meade M, Mehta S, Hodder R, Martin C, Heyland D, Marshall J, Rocker G, Peters S, Landry F, McDonald E, Soth M, Muscadere J, Campbell N, Guyatt G, Cook DJ, for The Canadian Critical Care Trials Group. Burden of illness in thromboembolism in critical care (BITEC) study: A Multicenter Canadian Study. Crit Care 2004; (suppl 1):S52, A103.
  108. Griffith L, Patel R, Cook DJ, Meade M, Mehta S, Hodder R, Martin C, Heyland D, Marshall J, Rocker G, Peter S, Landry F, McDonald E, Soth M, Guyatt G, for The Canadian Critical Care Trials Group. Burden of illness in thromboembolism in critical care (BITEC) Study. 10th International Symposium on Thrombosis, London, UK June 14, 2003 Abstract Book.
  109. Griffith L, Cook DJ, Hanna S, Rocker G, Sjokvist P, Dodek P, Marshall J, Levy M, Varon J, Finfer S, Jaeschke R, Buckingham L, Guyatt G, for The Canadian Critical Care Trials Group. Predictors of clinician discomfort with daily life support plans for mechanically ventilated patients. Critical Care; 7(suppl 2):S126.
  110. Mehta S, Burry L, Martinez C, Hallett DC, Wong C, Lapinsky S, Wax R, Cook DJ, Meade M, Stewart T, for The Canadian Critical Care Trials Group. A randomized trial of daily awakening in critically ill patients being managed with a sedation protocol. A pilot study.  Am J Resp Crit Care Med 2003;167(7):A970.
  111. Mehta S, Burry L, Martinez C, Fischer S, Bowman D, Hallet DC, Wong C, Cook DJ, Meade M, Stewart T, for The Canadian Critical Care Trials Group. A survey of Canadian physicians regarding the use of sedatives, analgesics, and neuromuscular blocking agents in mechanically ventilated adults in the intensive care unit. Am J Resp Crit Care Med 2003;167:A909.
  112. Rocker G, Cook DJ, Weaver B, Freitag A, Bradley C, McMullin J, Hamielec C, Guyatt GH, Marshall J, Sjokvist P, Dodek P, Freitag A, Varon J, Finfer S, Levy M, for the Level of Care Study Investigators and The Canadian Critical Care Trials Group. Withdrawal of mechanical ventilation in the intensive care unit. Crit Care Med 2003;7 (suppl 1):A84.
  113. Cook DJ, Weaver B, McDonald E, Guyatt GH, Rocker G, Finfer S, Kirby A, Levy M, Dodek P, Heyland D, Sjokvist P, Marshall J, for the Level of Care Study Investigators and The Canadian Critical Care Trials Group. Predicting mortality in the ICU. Crit Care Med 2003:A554.
  114. Dodek P, Keenan S, Heyland D, Cook DJ, Brun-Buisson C, Hall R, Jacka M, Foster D, Hand L, Mehta N, Muscedere J, for the Canadian Critical Care Society/Canadian Critical Care Trials Group. Development of a clinical practice guideline for prevention of ventilator-associated pneumonia (VAP). Am J Resp Crit Care Med 2002;165(8):A378.
  115. Herridge MS, Cheung AM, Tansley CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper A, Guest C, Maze D, Mehta S, Stewart TE, Bohn D, Cook DJ, Slutsky AS, and The Canadian Critical Care Trials Group. Long term clinical outcomes in survivors of ARDS. Am J Resp Crit Care Med 2002;165(8):A254.
  116. Cheung AM, Herridge MS, Tansley CM, Diaz-Granados N, Matte-Martyn A, Al-Saidi F, Cooper A, Guest C, Mazer D, Mehta S, Stewart T, Bohn D, Cook DJ, Slutsky AS, and The Canadian Critical Care Trials Group. Health care costs in survivors of ARDS. Am J Resp Crit Care Med 2002;165(8):A221.
  117. Sandham JD, Hull RD, Brant R, and The Canadian Critical Care Trials Group. A randomized controlled trial of pulmonary artery catheter use in 1994 high-risk geriatric surgical patients. Am J Resp Crit Care Med 2001;163:A16.
  118. Herridge MS, Cheung AM, Tansey C, Matte-Martyn A, Cooper A, Guest C, Mazer D, Mehta S, Stewart T, Bohn D, Cook DJ, Slutsky AS, and The Canadian Critical Care Trials Group. Long term clinical outcomes in survivors of ARDS. Am J Resp Crit Care Med 2000;163(5):A253.
  119. Cheung AM, Herridge MS, Tansey C, Matte-Martyn A, Cooper A, Guest C, Mazer D, Mehta S, Stewart T, Bohn D, Cook DJ, Slutsky AS, and The Canadian Critical Care Trials Group. Health services utilization in survivors of ARDS. Am J Resp Crit Care Med  2001;263(5):A252.
  120. Herridge MS, Cheung AM, Tansey C, Matte-Martyn A, Cooper A, Guest C, Mazer D, Mehta S, Stewart T, Bohn D, Cook DJ, Slutsky AS, and The Canadian Critical Care Trials Group. Survivors of ARDS: Clinical and economic sequelae.  Am J Resp Crit Care Med 2000;161(3):A382.
  121. Foster D, Steinberg M, Cook DJ, Granton J, Marshall J, for The Canadian Critical Care Trials Group. The impact of eligibility criteria on enrolment in ICU Sepsis Clinical Trials. Crit Care 1999;A23.
  122. Maziak DE, Todd TRJ, Dodek P, Hébert P, Herridge M, Heyland D, Kirby A, Meade M, and The Canadian Critical Care Trials Group. Can intensivists predict the length of ventilation of patients in the ICU? Clin Invest Med 1999;24(Suppl 4):A69.
  123. Herridge M, Cheung A, Tansey C, Matte-Martin A, Guest C, Mazer D, Stewart T, Slutsky A, Cook DJ, and The Canadian Critical Care Trials Group. Survivors of ARDS: A prospective multicenter cohort study of health outcomes and health care utilization. Am J Resp Crit Care Med 1999;159(3):A717.
  124. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C, and The Canadian Critical Care Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Resp Crit Care Med 1999;159(3):A263.
  125. Heyland DK, Cook DJ, Schoenfeld P, Johnston R, Freitag A, Wood G, Chin W, Varon J, Kirby A, and The Canadian Critical Care Trials Group. The effect of acidified enteral feeds on gastric colonization and pneumonia in critically ill patients: Results of a multicenter randomized trial. Am J Resp Crit Care Med 1999;159(3):A263.
  126. Heyland DK, Schoenfeld P, Luchsinger S, Wood G, Cook DJ, and The Canadian Critical Care Trials Group. The effect of acidified enteral feeds on contamination of the enteral feeding delivery system and subsequent colonization and infection in critically ill patients. Crit Care Med 1999;27(Suppl 1):A76.
  127. Heyland DK, Cook DJ, Marshall J, Heule M, Guslits B, Lang J, Jaeschke R, for The Canadian Critical Care Trials Group. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Crit Care Med 1999;27(Suppl 1):A161.
  128. Foster D, Cook DJ, Granton J, Steinberg M, Marshall J, for The Canadian Critical Care Trials Group. Use of a screen log to audit patient recruitment into multiple randomized trials in the ICU. Crit Care 1998;A69.
  129. Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, Blajchman M, Schweitzer I, Pagliarello G, for the Transfusion Requirements in Critical Care Trials and The Canadian Critical Care Trials Group. Does transfusion practice affect mortality in critically ill patients? Am J Resp Crit Care Med 1997;155(4):A20.
  130. Heyland D, Cook DJ, Leasa D, Freitag A, Heule M, Marshall J, et al, for The Canadian Critical Care Trials Group. The clinical utility of invasive diagnostic techniques for ventilator associated pneumonia. Am J Resp Crit Care Med 1996;153(4):A365.
  131. Sandham JD, Hull RD, Brant RF. Effect of the pulmonary artery catheter on morbidity and mortality, a multicenter trial. Am J Resp Crit Care Med 1996;153(4):A601.
  132. Meade MO, Cook DJ, Slutsky AS, Granton JT, Todd TRJ, Stewart ST, and the PLVS Study Group.  The Incidence of permissive hypercapnia in patients at high risk for ARDS using a pressure limited ventilation strategy. Clin Invest Med 1996;19:11.
  133. Griffith L, Cook DJ, Marshall J, for The Canadian Critical Care Trials Group. A comparison of APACHE II (Acute physiology and chronic health evaluation score) and MODS (Multiple organ dysfunction score) in predicting ICU mortality. Controlled Clinical Trials 1995;16(35):138S.
  134. Heyland D, Gafni A, Cook DJ, Guyatt GH, for The Canadian Critical Care Trials Group. An economic evaluation of stress ulcer prophylaxis in the Intensive Care Unit. Am J Resp Crit Care Med 1995;151:A495.
  135. Heyland D, Griffith L, Cook DJ, Guslits B, Heule M, Hewson JR, Powles P, for The Canadian Critical Care Trials Group. The clinical and economic consequences of clinically important gastrointestinal bleeding in the critically ill. Crit Care Med 1995;23(1 Suppl):A108.
  136. Hébert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, Blajchman M, for The Canadian Critical Care Trials Group. Transfusion requirements in critical care: A pilot study. Clin Invest Med 1995;18(Suppl 4):B26.
  137. Hébert PC, Wells G, Schweitzer I, Marshall J, Martin C, Tweeddale M, Pagliarello G, Blajchman M, Boisvert D, for The Canadian Critical Care Trials Group. Red cell transfusion practices in the critically ill: The Canadian experience. Clin Invest Med 1995;18(Suppl 4):B29.
  138. Cook DJ, King D, for The Canadian Critical Care Trials Group. How accurate are physician estimates of length of ICU stay and mechanical ventilation? Am J Resp Crit Care Med 1994;149(4):A640.
  139. Hébert P, Schweitzer I, Wells GA, Pagliarello G, Marshall J, Martin C, Tweeddale M, Calder L for the Canadian Critical Care Trials Group. A survey of red cell transfusion practices in Canadian critical care practitioners. Clin Invest Med 1994;17(Suppl 4):B22.
  140. Martin CM, Sibbald WJ, Luz X, Hébert P, Schweitzer I for the Canadian Critical Care Trials Group. Age of transfused red blood cells is associated with ICU length of stay. Clin Invest Med 1994;17(Suppl 4):B21.
  141. Cook DJ, for The Canadian Critical Care Trials Group. Withdrawal of life support in the   ICU: A national survey. Clin Invest Med 1993;16(Suppl):A49.
  142. Cook DJ, for The Canadian Critical Care Trials Group. Gastrointestinal hemorrhage in the critically ill population. Intens Care Med 1992;18(Suppl 2):A149.
  143. Cook DJ, Fuller H, for The Canadian Critical Care Trials Group. Gastrointestinal hemorrhage in the critically ill population. Clin Invest Med 192;15(Suppl)A24.
  144. Cook DJ, Fuller H, for The Canadian Critical Care Trials Group. Gastrointestinal hemorrhage in the critically ill population. Am Rev Res Dis 1992;145(4):A320.
  145. Cook DJ, Ling E, Jaeschke R, for The Canadian Critical Care Trials Group. The withdrawal of life support: Development and evaluation of a questionnaire. Am Rev Res Dis 1992;145(4):A82
  
     
 
 

Home | About Us | News & Events | Publications | Grants | Links
 

© 2005, CCCTG. All rights reserved.